In terms of market performance, Actinium Pharmaceuticals Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $9.56 on 03/21/23, while the lowest value was $4.00 on 11/28/23.
52-week price history of ATNM Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Actinium Pharmaceuticals Inc’s current trading price is -14.12% away from its 52-week high, while its distance from the 52-week low is 105.25%. The stock’s price range for this period has remained between $4.00 and $9.56. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.03 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.21 million over the last three months.
Financial Performance and Market Capitalization
Actinium Pharmaceuticals Inc (ATNM) has experienced a quarterly rise of 69.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 227.91M and boasts a workforce of 49 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.58, with a change in price of +2.81. Similarly, Actinium Pharmaceuticals Inc recorded 230,904 in trading volume during the last 100 days, posting a change of +52.04%.
ATNM Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ATNM stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.04.
ATNM Stock Stochastic Average
As of today, the raw stochastic average of Actinium Pharmaceuticals Inc over the past 50 days is 85.68%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 78.24%. Additionally, the Stochastic %K and %D values for the company were 40.75% and 30.88%, respectively, over the past 20 days.
ATNM Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 61.61% this year. Over the last six months, there has been a weaker performance of 32.63%. The price of ATNM fallen by 28.89% during the last 30 days period. For the last 5-days stocks have improved 24.58%.
